EASL 2014:3D-MRE可准确诊断NASH及晚期肝硬化

2014-04-14 佚名 dxy

与二维磁共振弹性成像技术(2D-MRE)相比,三维磁共振弹性成像(3D-MRE)做为一种评估肝脏硬度的新方法更加地可靠。 为了验证三维磁共振弹性成像诊断非酒精性脂肪性肝炎(NASH)和晚期肝硬化的准确性,来自加州大学圣地亚哥分校的Loomba教授进行了一项前瞻性队列研究。 研究包括了80名(54%为女性)经过活检证实为非酒精性脂肪性肝病(NAFLD)的患者。通过受试者工作特征曲线下面积(AUROC

与二维磁共振弹性成像技术(2D-MRE)相比,三维磁共振弹性成像(3D-MRE)做为一种评估肝脏硬度的新方法更加地可靠。

为了验证三维磁共振弹性成像诊断非酒精性脂肪性肝炎(NASH)和晚期肝硬化的准确性,来自加州大学圣地亚哥分校的Loomba教授进行了一项前瞻性队列研究。

研究包括了80名(54%为女性)经过活检证实为非酒精性脂肪性肝病(NAFLD)的患者。通过受试者工作特征曲线下面积(AUROC )来评估磁共振弹性成像对NASH和晚期肝硬化(分期≥3)的诊断价值。

研究包括NASH和non-NASH患者分别为70和10例。纤维化0、1、2、3、4期的患者分别为33、25、10、6和6例。磁共振弹性成像识别NASH的AUROC为0.852,识别晚期肝硬化的AUROC为0.969。

研究表明,三维磁共振弹性成像能准确地诊断非酒精性脂肪性肝炎及晚期肝硬化。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1301108, encodeId=2cf0130110865, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335831, encodeId=34801335831f1, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412512, encodeId=eb591412512dd, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519174, encodeId=c4b715191e480, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649493, encodeId=e6371649493cb, content=<a href='/topic/show?id=134912198dd' target=_blank style='color:#2F92EE;'>#MRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12198, encryptionId=134912198dd, topicName=MRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccd23846580, createdName=freve, createdTime=Sat Jan 10 10:55:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
    2014-04-16 kksonne
  2. [GetPortalCommentsPageByObjectIdResponse(id=1301108, encodeId=2cf0130110865, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335831, encodeId=34801335831f1, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412512, encodeId=eb591412512dd, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519174, encodeId=c4b715191e480, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649493, encodeId=e6371649493cb, content=<a href='/topic/show?id=134912198dd' target=_blank style='color:#2F92EE;'>#MRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12198, encryptionId=134912198dd, topicName=MRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccd23846580, createdName=freve, createdTime=Sat Jan 10 10:55:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1301108, encodeId=2cf0130110865, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335831, encodeId=34801335831f1, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412512, encodeId=eb591412512dd, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519174, encodeId=c4b715191e480, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649493, encodeId=e6371649493cb, content=<a href='/topic/show?id=134912198dd' target=_blank style='color:#2F92EE;'>#MRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12198, encryptionId=134912198dd, topicName=MRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccd23846580, createdName=freve, createdTime=Sat Jan 10 10:55:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
    2014-04-16 kord1983
  4. [GetPortalCommentsPageByObjectIdResponse(id=1301108, encodeId=2cf0130110865, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335831, encodeId=34801335831f1, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412512, encodeId=eb591412512dd, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519174, encodeId=c4b715191e480, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649493, encodeId=e6371649493cb, content=<a href='/topic/show?id=134912198dd' target=_blank style='color:#2F92EE;'>#MRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12198, encryptionId=134912198dd, topicName=MRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccd23846580, createdName=freve, createdTime=Sat Jan 10 10:55:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
    2014-04-16 lq1771
  5. [GetPortalCommentsPageByObjectIdResponse(id=1301108, encodeId=2cf0130110865, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335831, encodeId=34801335831f1, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412512, encodeId=eb591412512dd, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519174, encodeId=c4b715191e480, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Apr 16 04:55:00 CST 2014, time=2014-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649493, encodeId=e6371649493cb, content=<a href='/topic/show?id=134912198dd' target=_blank style='color:#2F92EE;'>#MRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12198, encryptionId=134912198dd, topicName=MRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccd23846580, createdName=freve, createdTime=Sat Jan 10 10:55:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
    2015-01-10 freve

相关资讯

JID:1b期研究发现ITX5061治疗HCV效果有限

慢性HCV感染可引起肝硬化和肝细胞癌,是肝相关疾病发病和死亡的主要原因。现有的HCV治疗并不尽如人意,存在毒性、效果局限和顺应性差等缺点。尽管在细节方面仍存在诸多不清之处,但是HCV进入细胞所需要的细胞受体包括清道夫受体B类1型(SR-B1)、CD81、紧密连接蛋白1和闭锁蛋白。存在于多种细胞(包括肝细胞)膜上的整合跨膜蛋白ITX5061是一个高效的小分子SR-B1抑制剂。因为抑制SR-B1与血浆

EASL 2014 :TIPS10mm支架控制门脉高压更效果更优

一个单中心、小样本的随机临床试验(RCT)曾显示,对于肝硬化难治性腹水的患者,使用直径为8mm的支架(聚四氟乙烯膨体覆盖)行TIPS手术并不能有效控制门脉高压,且容易引起并发症。为了进一步从临床应用方面证实此项研究,来自意大利巴勒莫的Luca等进行了一项回顾性研究,其结果公布于2014年4月9日-4月13日在伦敦举行的EASL2014会上。 研究选择了连续的171例采用直径8mm或直径10mm支架

EASL 2014:sofosbuvir+RBV对HCV肝硬化患者安全有效

HCV感染门静脉高压或肝硬化失代偿的患者,对于干扰素治疗的耐受性较差,低效,存在感染和死亡的风险。无干扰素治疗方案是一种理想的治疗。 哈佛大学Beth Israel Deaconess医学中心研究人员发现,sofosbuvir+利巴韦林治疗HCV肝硬化和门脉高压症(CPT 5-10)患者安全有效。该研究结果公布于2014年4月12日的EASL2014会议上。 患者随机接受48周的sofosbuvi

EASL 2014:uNGAL可预测急性失代偿肝硬化患者短期预后

中性粒细胞明胶酶相关脂质运载蛋白(NGAL)是一种22-kDa大小的蛋白,会在肾小管损伤后发生过表达。NGAL也会在其他类型细胞中发生过表达,特别是受炎症刺激的白细胞。在一般住院患者中,尿NGAL(uNGAL)是预测患者预后情况的重要指标,尤其是在肾衰竭和死亡率方面,但其在肝硬化患者中的相关信息却非常有限。 西班牙巴塞罗那IDIBAPS研究所Ariza等进行了一项多中心研究,通过检测尿中的NGAL

EASL 2014:SBP不利于肝硬化伴腹水患者NSBB治疗结局

患者自发性细菌性腹膜炎(SBP)进展后,维持循环系统储备是治疗的关键;而SBP的出现对肝硬化伴腹水的患者而言,可能使其失去了使用非选择性β受体阻滞剂(NSBB)治疗的机会。奥地利维也纳综合医院胃肠肝内科的Mandorfer等对此进行了研究探讨。 该队列研究连续纳入607例肝硬化患者,这些患者首次接受穿刺腹水放液治疗。Cox模型分析NSBB治疗对SBP发病率和非肝移植生存率的影响。SBP发病率模型通

EASL 2014 :CT测定腰大肌厚度可判断肝硬化患者预后

长期以来,对于终末期肝病都没有一个较完善的评分指标以评价其严重程度。终末期肝病模型(Model for end-stage liver disease,MELD)标准可对终末期肝病短中期死亡率进行有效的预测,并因其评价指标易得、客观、易于计算,在肝病诊治中广为应用。 然而,MELD分级中使用的血清肌酐、胆红素、INR等指标,容易受非肝病因素的影响,这将直接影响判断真实的肝病病情。对于MELD评分较